USP drug safety review #2 - The dangers associated with vaccinations
Why Pharmacists Should Never Rely Solely on AI's OTC Recommendations | APhA 2025
Dan Krinsky, BS, MS, discussed the use of ChatGPT and large-language models in assisting pharmacists for the management of OTC self-care products.
What is Being Done to Address Pharmacy Deserts in the US?
Cencora representatives with expertise into pharmacy desert insights joined Drug Topics to discuss issues in pharmacy access and what is being done to address them.
Pharmacists’ Expertise in Contraceptive Counseling Amid Ongoing Challenges | APhA 2025
Jasmine Cutler, PharmD, discussed the unique expertise pharmacists possess in order to counsel patients seeking any type of contraceptive product.
What Does the Future of Pain Medicine Look Like?
With minimal pharmacological treatments coming to market for chronic pain, researchers have explored new technologies for advancing pain treatment across the globe.
Stopping SSRIs, SNRIs During Pregnancy Not Linked to Adverse Psychiatric Outcomes
Discontinuing SSRIs or SNRIs during pregnancy did not lead to an increase in hospitalizations, outpatient visits, suicidal behavior, or sick leave use.
Q&A: Community Pharmacists Well-Positioned to Provide Injectable Contraception
Nicole Cieri-Hutcherson, PharmD, BCPS, MSCP, FCCP, clinical associate professor at University at Buffalo, discusses how pharmacists and patients view injectable contraception.
